Minimizing red blood cell contamination while isolating mononuclear cells from whole blood: the next step for the treatment of severe hemolytic disease of the fetus/newborn

MLA

Rod Farb, et al. “Minimizing Red Blood Cell Contamination While Isolating Mononuclear Cells from Whole Blood: The next Step for the Treatment of Severe Hemolytic Disease of the Fetus/Newborn.” American Journal of Obstetrics and Gynecology, vol. 189, Oct. 2003, pp. 1012–16. EBSCOhost, https://doi.org/10.1067/s0002-9378(03)00813-5.

APA

Rod Farb, Susan M Orton, Kenneth J. Moise, Lalitha Subramanyam, & Garrett K Lam. (2003). Minimizing red blood cell contamination while isolating mononuclear cells from whole blood: the next step for the treatment of severe hemolytic disease of the fetus/newborn. American Journal of Obstetrics and Gynecology, 189, 1012–1016. https://doi.org/10.1067/s0002-9378(03)00813-5

Chicago

Rod Farb, Susan M Orton, Kenneth J. Moise, Lalitha Subramanyam, and Garrett K Lam. 2003. “Minimizing Red Blood Cell Contamination While Isolating Mononuclear Cells from Whole Blood: The next Step for the Treatment of Severe Hemolytic Disease of the Fetus/Newborn.” American Journal of Obstetrics and Gynecology 189 (October): 1012–16. doi:10.1067/s0002-9378(03)00813-5.